Page Menu

Recent Publications

Baltz JO, Jellinek NJ. Commentary on Transungual Excision of Glomus Tumors. Dermatol Surg 2020 Jan.

Knackstedt TJ, Baltz JO, Wilmer EN, Jellinek NJ. Assessing patient outcomes after digit-spairing en bloc surgery of nail apparatus melanoma in situ using two validated surveys. J Am Acad Dermatol 2019 Jul 23.

Baltz JO, Telang GH, Jellinek NJ. Subungual Caliber Persistent Artery of the Nail Unit Coincident with Onychopapilloma. Dermatol Surg 2019 Sep 30.

Baltz JO, Jellinek NJ. Reconstruction of a Defect Involving the Cupid's Bow. Dermatol Surg 2019 Sep 30.

Van Geel N, Wolkerstorfer A, Ezzedine K, Pandya AG, Bekkenk M, Grine L, Van Belle S, Lommerts JE, Hamzavi l, Harris JE, Eleftheriadou V, Esmat S, Kang HY, Kumarasinghe P, Lan CE, Parsad D, Raboobee N, Flora Xiang L, Suzuki T, Prinsen CA, Taieb A, Picardo M, Speeckaert R; participants of the Rome International VGICC/VIS Workshop. Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting. 2019 Sep

Berrebi KG, Orlowski GM, Richey JD, Levin NA. Multiple atypical vascular lesions following breast-conserving surgery and radiatio. Cutis. 2019 Jun.

Tkachenko E, Blankenship K, Goldberg D, Scharf MJ, Weedon S, Levin NA. Dish soap for complete tick detachment. J Am Acad Dermaol. 2019 June 13. 

Richmond JM, Strassner JP, Essien Kl, Harris JE. T-cell positioning by chemokines in autoimmune skin diseases. 2019 May

Tkachenko E, Refat MA, Balzano T, Maloney ME, Harris JE. Patient satisfaction and physician productivity in shared medical appointments for vitiligo. J Am Acad Dermatol. 2019 Nov.

Evan-Browning E, Rork J, O'Donnell P, Elaba Z, Deng A, Wiss, K. Verruciform xanthoma in recessive dystrophic epidermolysis bullosa and keratitis-ichthyosis-deafness syndrome: Report of two cases and a review of the literature. Pediatr Deramtol. 2019 Nov 11.

Lal K, Morrell TJ, Cunningham M, O’Donnell P, Levin NA, Cornejo KM. A case of a malignant cutaneous mixed tumor (chondroid syringomas) of the scapula treated with staged margin-controlled excision. Am J Dermatopathol 2018;40:679-81. 

Petkiewicz S, Baltz J, Cornejo K, Deng A, Wiss K. Widespread presentation and spontaneous regression of porokeratotic eccrine ostial and dermal duct nevus. JAAD Case Rep 2018;4:972-5.

Feinstein JA, Jambal P, Peoples K, Lucky A, Khuu P, Tang JY, Lara-Corrales I, Pope E, Wiss K, et al. Assessment of the timing of milestone clinical events in patients with epidermolysis bullosa from North America. JAMA Dermatol 2018;epub ahead of print 12/26/2018.

Van Geel N, Wolkerstorfer A, Lommerts JE, Ezzedine K, Eleftheriadou V, Hamzavi I, Harris J, Picardo M, Taieb A, Prinsen CA, Bekkenk M, and Speeckaert R. Validation study of the vitiligo extent core-plus (VESplus). J Am Acad Derm 2018;78:1013-5.

Korta DZ, Christiano AM, Bergfeld W, Duvic M, Ellison A, Fu J, Harris JE, Hordinsky MK, King B, Kranz D, Mackay-Wiggan J, McMichael A, Norris DA, Price V, Shapiro J, and Atanaskova-Mesinkovska N. Alopecia areata is a medical disease. J Am Acad Derm 2018;78: 832-4.

Van Geel N, Bekkenk M, Lommerts JE, Ezzedine K, Harris J, Hamzavi I, Eleftheriadou V, Picardo M, Taieb A, Prinsen C, Wolkerstorfer A, and Speeckaert R. The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo. J Am Acad Derm 2018; ePub ahead of print.

Mande P, Zirak B, Ko WC, Taravati K, Bride KL, Brodeur TY, Deng A, Dresser K, Jiang Z, Ettinger R, Fitzgerald KA, Rosenblum MD, Harris JE, and Marshak-Rothstein A. Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation. J Clin Invest 2018; ePub ahead of print.

 Rork JF, Prindaville B, Dalla Costa R, Wiss K. Response to “Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas”. Pediatr Dermatol 2018;35:700

 Winkler A, Prindaville B, Wiss K. Curvilinear erythematous plantar patch in a toddler. Pediatr Dermatol 2018;35:251-2.

Dalla Costa R, Prindaville B, Wiss K. Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas. Pediatric Dermatol 2018;35:276-7.

McDermott LE, Midura M, Papagermanos V, Kirby J, Wanat KA, Belazarian LT, Dunnick C, Mounessa JS, Savory SA, Avashia-Khemka N, Strunk A, Garg A. Satisfaction with care and likelihood to recommend ratings attributed to dermatology trainees. J Am Acad Dermatol 2018;78:610-2.

Prindaville B, Belazarian L, Levin NA, Wiss K. Pityrosporum folliculitis: A retrospective review of 110 cases. J Am Acad Dermatol 2018;78:511-4.

Richmond J, Strassner JP, Zapata L Jr., Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, and Harris JE. Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo. Science Transl Med 2018;10:1-9.

Droms RJ, Snadecki H, Deng A, Levin NA. Lichen planus pigmentosus in a blaschkoid distribution. Dermatol Online J 2017;23 (6).

Krueger S, Rork J, Lee J, Cornejo K, Gibson L, Daly JS, Levin NA. Mycobacterium haemophilum infection in a renal transplant patient with inflammatory bowel disease. Dermatol Online J 2017;23(9).

Li AW, Prindaville B, Bateman ST, Gibson TE, Wiss K. Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review. Pediatr Dermatol 2017;34:647-55.

Kane J, Berrebi K, McLean R, Petkiewicz S, Hay B, Martin M, Wiss K. Noonan syndrome with loose anagen hair associated with trichorrhexis nodosa and trichoptilosis. Clin Case Rep 2017;5:1152-4.

Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS; Psoriasis Investigator Group (PsIG) of the Pediatric Dermatology Research Alliance and the European Working Group on Pediatric Psoriasis (EWGPP). Safety of systemic agents for the treatment of pediatric psoriasis. JAMA Dermatol 2017;153:1147-57.

Droms RJ, Rork JF, McLean R, Martin M, Belazarian L, Wiss K. Menkes disease mimicking child abuse. Pediatr Dermatol 2017;34:e132-4.

Gan EY, Eleftheriadou V, Esmat S, Hamzavi I, Passeron T, Böhm M, Anbar T, Goh BK, Lan CE, Lui H, Ramam M, Raboobee N, Katayama I, Suzuki T, Parsad D, Seth V, Lim HW, van Geel N, Mulekar S, Harris J, Wittal R, Benzekri L, Gauthier Y, Kumarasinghe P, Thng ST, Silva de Castro CC, Abdallah M, Vrijman C, Bekkenk M, Seneschal J, Pandya AG, Ezzedine K, Picardo M, Taïeb A; VGICC. Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference (VGICC). Pigment Cell & Melanoma Research. 2017;30: 28-40.

Richmond JM, Essien KI, BangariDS, CurrimbhoySD, GroomJR, PandyaAG, YoudME, LusterAD, HarrisJE. Keratinocyte-derived chemokines orchestrate T cell positioning in the epidermis during vitiligo and may serve as biomarkers of disease. J Invest Dermatol 2017;137: 350-8.

Richmond JM, Masterjohn E, Chu R, Tedstone J, YoudME, HarrisJE. CXCR3 depleting antibodies prevent and reverse vitiligo in mice. J Invest Dermatol 2017;137: 982-5.

Mohammad TF, Al-Jamal M, Hamzavi IH, Harris JE, Leone G, Cabrera R, Lim HW, Pandya AG, and Esmat SM. The Vitiligo Working Group recommendations for narrowband ultraviolet B treatment of vitiligo. J Am Acad Dermatol 2017;76: 879-88.

Strassner J, Rashighi M, Refat MA, Richmond JM, and Harris JE. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol 2017;76: 847-55.

Van Geel N, Boniface K, Seneschal J, Jacquemin C, Speeckaert R, Wolkerstorfer  A, Bekkenk M, Lommerts JE, Hamzavi I, Pandya A, Eleftheriadou V, Ezzedine K, Giannarelli D, Gnarra M, Sperduti I, Prinsen C, Harris J, Taieb A, Picardo M. Meeting report: Vitiligo Global Issues Consensus Conference (VGICC) Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd. Pigment Cell & Melanoma Research. 2017;30:436-43.

Liu LY, Strassner JP, Refat MA, Harris JE*, and King BA*. Repigmentation in vitiligo using the janus kinase inhibitor, tofacitinib, requires concomitant light exposure. J Am Acad Dermatol 2017; 77: 675-82.

Vanderweil SG, Amano SU, Ko W, Richmond JM, Rashighi M, Kelley M, Makredes-Senna M, Pearson A, Chowdary S, Hartigan C, Barton B, Harris JE. A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo. J Amer Acad Dermatol 2017;76:150-1.